It was the combination of "layoffs" and "artificial intelligence" that stoked broader concern for an AI-driven shock to the labor market, leaving many to wonder whether Jack Dorsey's payments company ...

Block Inc. (Nasdaq: XYZ), Jack Dorsey's Bitcoin-centric fintech company reported the financial results for Q4 2025 on Feb. 26. The company generated adjusted earnings per share (EPS) of $0.65 on ...

Blockchain technology continues to evolve rapidly with scalability and efficiency as key challenges. Recursive SNARKs (Succinct Non-Interactive Arguments of Knowledge) have emerged as a breakthrough ...

Jack Dorsey’s decision to lay off hundreds of employees and aggressively promote the use of artificial intelligence at his financial services company, Block Inc., has led to riled workers downgrading ...

Filing taxes is a pain. Here’s how H&R Block DIY and Assisted performed against other services I tested. I've been through the wringer with my taxes the past couple of years. Last year, I was a ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.85, moving -3.27% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.33%. On ...

Among the two rumored flavors, Qualcomm is expected to bring LPDDR6 RAM and a full-fledged GPU for only the Snapdragon 8 Elite Gen 6 Pro. A newly leaked block diagram now suggests the Pro chip may ...

Jack Dorsey’s Block Inc. has been notifying hundreds of employees that their jobs may be eliminated during annual performance reviews as the payments firm embarks on a broader business overhaul. Up to ...

According to God of Prompt on Twitter, MIT researchers have introduced a new prompt engineering technique called 'Recursive Meta-Cognition' that enables ChatGPT to reason like a team of experts rather ...

Sen. Thom Tillis, R-N.C., said he will block any Trump Fed nominees, including for chair, in light of revelations that the Justice Department is investigating Jerome Powell for potential perjury ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.